Elisabetta Poluzzi

8.8k total citations · 1 hit paper
158 papers, 5.1k citations indexed

About

Elisabetta Poluzzi is a scholar working on Toxicology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Elisabetta Poluzzi has authored 158 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Toxicology, 32 papers in Cardiology and Cardiovascular Medicine and 28 papers in Pharmacology. Recurrent topics in Elisabetta Poluzzi's work include Pharmacovigilance and Adverse Drug Reactions (36 papers), Cardiac electrophysiology and arrhythmias (18 papers) and Health Systems, Economic Evaluations, Quality of Life (16 papers). Elisabetta Poluzzi is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (36 papers), Cardiac electrophysiology and arrhythmias (18 papers) and Health Systems, Economic Evaluations, Quality of Life (16 papers). Elisabetta Poluzzi collaborates with scholars based in Italy, Netherlands and United Kingdom. Elisabetta Poluzzi's co-authors include Fabrizio De Ponti, Emanuel Raschi, Nicola Montanaro, Maurizio Recanatini, Andrea Cavalli, Carlo Piccinni, Domenico Motola, Ugo Moretti, Giulio Marchesini and Michele Fusaroli and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Elisabetta Poluzzi

153 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems

2024 66 citations Paola Maria Cutroneo, Daniele Sartori et al. SHILAP Revista de lepidopterología profile →

Peers

Countries citing papers authored by Elisabetta Poluzzi

Since Specialization

Citations

This map shows the geographic impact of Elisabetta Poluzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Poluzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Poluzzi more than expected).

Fields of papers citing papers by Elisabetta Poluzzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Poluzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Poluzzi. The network helps show where Elisabetta Poluzzi may publish in the future.

Co-authorship network of co-authors of Elisabetta Poluzzi

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Poluzzi. A scholar is included among the top collaborators of Elisabetta Poluzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Poluzzi. Elisabetta Poluzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disproportionality analysis on semaglutide and nonarteritic anterior ischemic optic neuropathy in the FDA adverse event reporting system: An emerging pharmacovigilance signal? 2025 ·Obesity Research & Clinical Practice ·(unknown), Elisabetta Poluzzi, Fabrizio De Ponti, Emanuel Raschi	6
2	The prevalence of polypharmacy in older Europeans: A multi‐national database study of general practitioner prescribing 2024 ·British Journal of Clinical Pharmacology ·Marion Bennie, Yared Santa‐Ana‐Téllez, (unknown), (unknown), (unknown), Laurence S. Jouaville, Elisabetta Poluzzi, Lucas Morin, Ingrid Schübert, Seán MacBride‐Stewart, Monique Elseviers, (unknown), Katja Taxis	11
3	Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports 2024 ·Journal of Clinical Psychopharmacology ·Michele Fusaroli, Charles Khouri, Elisabetta Poluzzi, Fabrizio De Ponti, Francesco Salvo, Emanuel Raschi	2
4	Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems breakdown → 2024 ·SHILAP Revista de lepidopterología ·Paola Maria Cutroneo, Daniele Sartori, Marco Tuccori, Salvatore Crisafulli, Vera Battini, Carla Carnovale, Concetta Rafaniello, Annalisa Capuano, Elisabetta Poluzzi, Ugo Moretti, Emanuel Raschi	66
5	Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System 2023 ·Journal of Speech Language and Hearing Research ·Michele Fusaroli, Arndis Simonsen, Stephanie A. Borrie, Daniel M. Low, Alberto Parola, Emanuel Raschi, Elisabetta Poluzzi, Riccardo Fusaroli	7
6	Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study 2022 ·Pharmacoepidemiology and Drug Safety ·Iva Selke Krulichová, Gisbert Selke, Marion Bennie, (unknown), Fredrik Nyberg, Jurij Fürst, Kristina Garuolienė, Elisabetta Poluzzi, Juraj Slabý, Corinne Zara, Mattia Altini, Maria Pia Fantini, Václav Kočí, Stuart McTaggart, Caridad Pontes, Chiara Reno, (unknown), (unknown), (unknown), Björn Wettermark	26
7	Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies 2022 ·International Journal of Environmental Research and Public Health ·Manuela Casula, Federica Galimberti, Marica Iommi, Elena Olmastroni, Simona Rosa, Mattia Altini, Alberico L. Catapano, Elena Tragni, Elisabetta Poluzzi	5
8	Time-Trends of Drug-Drug Interactions among Elderly Outpatients in the Piedmont Region (Italy): A Population-Based Study 2022 ·International Journal of Environmental Research and Public Health ·(unknown), Lorenza Scotti, (unknown), (unknown), Daniela Ferrante, Elisabetta Poluzzi, Armando A. Genazzani, Francesco Barone‐Adesi	2
9	Global prevalence of antidepressant drug utilization in the community: protocol for a systematic review 2022 ·BMJ Open ·Carlotta Lunghi, Michèle Dugas, Jacinthe Leclerc, Elisabetta Poluzzi, (unknown), (unknown), (unknown), (unknown), Johanie Lépine, (unknown), Nataly R. Espinoza Suárez, (unknown), (unknown), (unknown), (unknown), (unknown), Stéphane Turcotte, Becky Skidmore, Annie LeBlanc	10
10	Identifying ethical values for guiding triage decisions during the COVID-19 pandemic: an Italian ethical committee perspective using Delphi methodology 2021 ·BMJ Open ·(unknown), Giovanni Brandi, Giuseppe Di Pasquale, (unknown), P. De Carolis, Francesca Bravi, Francesco Pugliese, Elisabetta Poluzzi, Fausto Catena, Filippo Giovanardi, Giorgia Valpiani, (unknown), (unknown), Primiano Iannone	5
11	Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list 2021 ·Parkinsonism & Related Disorders ·Michele Fusaroli, Emanuel Raschi, Manuela Contin, Luisa Sambati, Marco Menchetti, Angelo Fioritti, Elisabetta Poluzzi	7
12	Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study 2020 ·SHILAP Revista de lepidopterología ·Carlotta Lunghi, (unknown), (unknown), Emanuel Raschi, (unknown), (unknown), (unknown), Marco Menchetti, Pasquale Roberge, Elisabetta Poluzzi	0
13	Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 2019 ·PLoS ONE ·(unknown), Ippazio Cosimo Antonazzo, Carlo Piccinni, Emanuel Raschi, (unknown), Angelo Fioritti, Domenico Berardi, Fabrizio De Ponti, (unknown), Elisabetta Poluzzi	3
14	Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems 2018 ·Drug Safety ·Emanuel Raschi, Anna Girardi, Elisabetta Poluzzi, (unknown), Francesca Menniti‐Ippolito, Gabriela Mazzanti, Fabrizio De Ponti	24
15	La centralità del paziente nella terapia antipsicotica: condivisione del trattamento, aderenza e ricerca 2015 ·Recenti Progressi in Medicina ·(unknown), Carlo Piccinni, (unknown), Elisabetta Poluzzi, Marco Menchetti, Domenico Berardi	1
16	Pro-Arrhythmic Potential of Oral Antihistamines (H1): Combining Adverse Event Reports with Drug Utilization Data across Europe 2015 ·PLoS ONE ·Elisabetta Poluzzi, Emanuel Raschi, Brian Godman, Ariola Koci, Ugo Moretti, Marija Kalaba, Björn Wettermark, Miriam Sturkenboom, Fabrizio De Ponti	53
17	Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 2010 ·European Journal of Clinical Pharmacology ·Elisabetta Poluzzi, Carlo Piccinni, Paolo Carta, Aurora Puccini, Monica Lanzoni, Domenico Motola, Alberto Vaccheri, Fabrizio De Ponti, Nicola Montanaro	22
18	Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents 2009 ·European Journal of Clinical Pharmacology ·Carlo Piccinni, (unknown), Elisabetta Poluzzi, Domenico Motola, Lara Magro, Ugo Moretti, Anita Conforti, Nicola Montanaro	25
19	Adherence to statin therapy and patients’ cardiovascular risk: a pharmacoepidemiological study in Italy 2008 ·European Journal of Clinical Pharmacology ·Elisabetta Poluzzi, (unknown), Monica Lanzoni, (unknown), (unknown), Domenico Motola, A. Gaddi, Alberto Vaccheri, Nicola Montanaro	33
20	Safety of Non-Antiarrhythmic Drugs that Prolong the QT Interval or Induce Torsade de Pointes 2002 ·Drug Safety ·Fabrizio De Ponti, Elisabetta Poluzzi, Andrea Cavalli, Maurizio Recanatini, Nicola Montanaro	247

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact